Personalis Inc. Logo

Personalis Inc. (PSNL)

NASDAQ

Currency in USD
17.06
-0.19 (-1.10%)

Closed

Aug 26, 2026

Day's Range

16.85
17.49

52 wk Range

4.65
18.89

Profile - PSNL - Personalis Inc.

Profile

Mic Code

XNMS

Sector

Healthcare

Industry

Diagnostics & Research

Employees

259


Personalis Inc. is a biotechnology company specializing in advanced genomics services for precision medicine and oncology. Its primary function is to analyze complex genetic information for clinical and academic research, aiding in the development of targeted therapeutics and personalized treatments. The company's offerings include a comprehensive platform that integrates genomic data generation with advanced bioinformatics, focusing particularly on cancer genomics and the immune response. Personalis Inc. collaborates with leading research institutions, biopharmaceutical companies, and healthcare providers to enhance the understanding of disease mechanisms and improve therapeutic strategies. Headquartered in Menlo Park, California, Personalis plays a significant role in the biotech industry by contributing to innovations in personalized healthcare, precision diagnostics, and genomics-driven therapeutic development.

Profile Details

Type

Common Stock

Ceo

Mr. Christopher M. Hall

Address

6600 Dumbarton Circle

City

Fremont

State

CA

Zip

94555

Country

United States

Phone

650 752 1300

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.